Delivery Order SPE2DB20D7059-SPE2DB25FQME2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $18,464.42 to AmerisourceBergen Drug Corp for the supply of Vaxelis vaccine in 0.5mL vials. This firm fixed-price delivery order, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a competitive award with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Vaxelis vaccine vials (0.5 mL). This firm fixed-price delivery order, valued at $2,591.38, is not set-aside and represents a competitively awarded transaction. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 28, 2025. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a $7,774.14 delivery order to AmerisourceBergen Drug Corp for Vaxelis vaccine vials (0.5 mL) on September 15, 2025, with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,855.18 firm fixed-price delivery order for Vaxelis vaccine vials (0.5ML) on June 5, 2025, with completion scheduled for June 6, 2025. This non-set-aside delivery order was competitively awarded and performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's extensive role as a critical pharmaceutical and medical supply vendor to the...
- The Defense Logistics Agency awarded a delivery order valued at $5,791.57 to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5 mL) on August 20, 2025, with completion scheduled for August 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) valued at $6,394.80 under a firm fixed-price contract. The award, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a non-set-aside competitively awarded delivery order. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, will perform this work...
- The Defense Logistics Agency awarded a delivery order valued at $1,278.96 to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5ml) on September 22, 2025, with an ultimate completion date of September 23, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine medical supply procurement under the company's existing contract vehicle...
- The Defense Logistics Agency has awarded a $7,061.01 delivery order to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL). This competitively awarded, firm fixed-price contract with an ultimate completion date of October 30, 2025, represents a single delivery order fulfillment under AmerisourceBergen's larger federal contract vehicle. The work will be performed at the company's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this...
- The Defense Logistics Agency awarded a $3,499.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vaxelis vaccine vials (0.5 mL) with an ultimate completion date of September 9, 2025. This non-set-aside contract was awarded competitively on September 8, 2025, with performance at the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) valued at $2,557.92 under a firm fixed-price contract type. The award was made on August 12, 2025, with an ultimate completion date of August 13, 2025, and utilized no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FQME2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vaxelis vaccine vials (0.5mL) valued at $12,956.80 under a firm fixed-price contract with an ultimate completion date of July 28, 2025. This non-set-aside delivery order, issued on July 25, 2025, represents a discrete transaction under AmerisourceBergen's broader pharmaceutical supply relationship with DLA, with performance to occur at the company's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, supplies a wide range of medical products including vaccines, brand-name and generic medications, and specialized medical devices to support military healthcare systems and other federal medical procurement needs. The company's competitively awarded contracts with DLA demonstrate substantial capability in fulfilling diverse pharmaceutical supply requirements for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.0k | 7/25/25 |